We are live on ! Find out more
SFG

SVB Financial Group Portfolio holdings

AUM $434K
1-Year Est. Return 277.67%
This Fund
S&P 500
This Quarter Est. Return
+110.07%
1 Year Est. Return
+277.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
+$59.7M
Cap. Flow
+$9.4M
Cap. Flow %
8.33%
Top 10 Hldgs %
99.96%
Holding
23
New
2
Increased
2
Reduced
1
Closed
10

Top Buys

Rank Stock Value
1
COIN icon
Coinbase
COIN
+$13.6M
2
ML
MoneyLion Inc.
ML
+$125K
3
PACB icon
Pacific Biosciences
PACB
+$84.5K
4
GETR
Getaround, Inc.
GETR
+$6.03K

Top Sells

Rank Stock Value
1
GPCR icon
Structure Therapeutics
GPCR
+$1.78M
2
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$922K
3
ROVR
Rover Group, Inc. Class A Common Stock
ROVR
+$661K
4
CMAX
CareMax, Inc. Class A Common Stock
CMAX
+$636K
5
CGEM icon
Cullinan Oncology
CGEM
+$122K

Sector Composition

Rank Sector Weight
1 Financials 89.38%
2 Technology 6.38%
3 Healthcare 3.6%
4 Industrials 0.38%
5 Consumer Discretionary 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COIN icon
1
Coinbase
COIN
$39.5B
$92.4M 81.9%
531,319
+124,346
+31% +$13.6M
ROOT icon
2
Root
ROOT
$954M
$8.21M 7.27%
783,012
– –
OKTA icon
3
Okta
OKTA
$25.6B
$7.17M 6.35%
79,152
– –
AXSM icon
4
Axsome Therapeutics
AXSM
$11B
$2.69M 2.39%
33,849
– –
OBIO icon
5
Orchestra BioMed
OBIO
$253M
$1.16M 1.03%
127,068
– –
PL icon
6
Planet Labs
PL
$7.97B
$425K 0.38%
172,097
– –
ML
7
DELISTED
MoneyLion Inc.
ML
$234K 0.21%
+3,729
New +$125K
GLBE icon
8
Global E Online
GLBE
$6.98B
$203K 0.18%
5,114
– –
PACB icon
9
Pacific Biosciences
PACB
$404M
$202K 0.18%
20,586
+10,337
+101% +$84.5K
FIRY
10
Firy Inc
FIRY
$154M
$86.8K 0.08%
13,950
– –
MVLA
11
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$33.6K 0.03%
55,528
– –
GETR
12
DELISTED
Getaround, Inc.
GETR
$6.37K 0.01%
+27,094
New +$6.03K
MKUL
13
DELISTED
Molekule Group, Inc. Common Stock
MKUL
$142 ﹤0.01%
14,165
-7,082
-33% -$862
CGEM icon
14
Cullinan Oncology
CGEM
$1.08B
– –
-13,516
Closed -$122K
CRBU icon
15
Caribou Biosciences
CRBU
$160M
– –
-20,714
Closed -$99K
ELDN icon
16
Eledon Pharmaceuticals
ELDN
$266M
– –
-13,472
Closed -$18.5K
GBIO
17
DELISTED
Generation Bio
GBIO
– –
-2,503
Closed -$94.9K
GPCR icon
18
Structure Therapeutics
GPCR
$3.59B
– –
-35,353
Closed -$1.78M
MLTX icon
19
MoonLake Immunotherapeutics
MLTX
$1.49B
– –
-16,173
Closed -$922K
VERO
20
DELISTED
Venus Concept
VERO
– –
-970
Closed -$20.9K
KLRS
21
Kalaris Therapeutics
KLRS
$99.7M
– –
-748
Closed -$37K
ROVR
22
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
– –
-105,534
Closed -$661K
CMAX
23
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
– –
-10,000
Closed -$636K

Similar funds

RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
CBFP
Cedar Brook Financial Partners Cleveland, Ohio $698K AUM 46.64% 1-Year Est. Return
BP
BFAM Partners Northpoint, Hong Kong, Hong Kong $44K AUM 8.69% 1-Year Est. Return
SLA
SWaN & Legend Advisors Leesburg, Virginia $841K AUM 23.47% 1-Year Est. Return
SG
Stagwell Group Miami Beach, Florida $913K AUM 49.68% 1-Year Est. Return
AFG
AFS Financial Group Bethesda, Maryland $1.15M AUM 23.97% 1-Year Est. Return
K
Kemper Chicago, Illinois $1.2M AUM 20.64% 1-Year Est. Return
MIG
MGG Investment Group New York $1.36M AUM 20.76% 1-Year Est. Return

SVB Financial Group's Q4 2023 Portfolio in Review

As of Q4 2023, SVB Financial Group held 23 positions worth $113M, up 112% from $53.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SVB Financial Group deployed $9.4M of net new capital in Q4 2023, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was MoneyLion Inc.: 3,729 shares worth $234K.

By sector, the portfolio is most concentrated in Financials at 89% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Molekule Group, Inc. Common Stock, an estimated $862 trimmed.

  • SVB Financial Group's largest Q4 2023 buy was MoneyLion Inc.: 3,729 shares worth $234K.
  • SVB Financial Group added most to Coinbase in Q4 2023, an estimated $13.6M increase.
  • SVB Financial Group's biggest Q4 2023 reduction was Molekule Group, Inc. Common Stock, cutting an estimated $862.
  • SVB Financial Group fully exited Structure Therapeutics in Q4 2023, selling an estimated $1.78M.
  • SVB Financial Group's ten largest holdings make up 100% of its $113M portfolio in Q4 2023.
  • SVB Financial Group opened 2 new positions and closed 10 in Q4 2023.
  • SVB Financial Group's portfolio value rose 112% quarter-over-quarter to $113M.

Based on SVB Financial Group's 13F filing for Q4 2023, filed 14 Feb 2024.